Skip to search formSkip to main contentSkip to account menu

500 ML Sodium Chloride 9 MG/ML Injection

Known as: SODIUM CHLORIDE 9 g in 1000 mL INTRAVENOUS INJECTION, SOLUTION_#2, SODIUM CHLORIDE 900 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Veterinary 0.9% Sodium Chloride]_#1, Sodium Chloride 0.9 g in 100 mL SUBCUTANEOUS INJECTION, SOLUTION [Sterile Saline]_#2 
National Institutes of Health

Related topics

Related topics

18 relations
AlkalosisChloride IonCorneal edemaDehydration

Broader (1)

Sodium Chloride 9 MG/ML Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
ЭКСТРАКОРПОРАЛЬНАЯ ФОТОХИМИОТЕРАПИЯ ТИПИЧНОГО И АТИПИЧНОГО КРАСНОГО ПЛОСКОГО ЛИШАЯ
Background: Lichen planus rubrum (LPR) belongs to the group of papulosquamous dermatoses. Pathophysiology of this most common… 
2012
2012
Comparing peripheral blood stem cell collection using the COBE Spectra, Haemonetics MCS+, and Baxter Amicus.
2006
2006
In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set
Pathogen inactivation using the INTERCEPT Blood System™ requires platelet resuspension in InterSol™ and reduced plasma. Platelets… 
2006
2006
Prospective randomised comparison of the COBE Spectra version 6 and Haemonetics MCS+ cell separators for hematopoietic progenitor cells leucapheresis in patients with multiple myeloma
A randomised crossover trial of two separators was undertaken to compare the mononuclear cell, CD34+ cell and CFU‐GM yield, in… 
2002
2002
Phosphatidylserine exposure in platelet concentrates during the storage period: differences between the platelets collected with different cell separators.
2001
2001
Unintentional platelet removal by plasmapheresis
Therapeutic plasmapheresis may remove platelets as well as plasma. Unintentional platelet loss, if not recognized, may lead to… 
2001
2001
Prospective randomised concurrent comparison of the COBE spectra version 4.7, COBE spectra version 6 (Auto PBSCtrade mark), and haemonetics MCS+ cell separators for leucapheresis in patients with…
2001
2001
Prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (Auto PBSC™), and Haemonetics MCS+ cell separators for leucapheresis in patients with…
A prospective study of three cell separators was undertaken to compare the mononuclear cell, CD34+ cell and CFU‐GM yield. Twenty… 
2001
2001
Cascade Filtration (CF) with the Haemonetics MCS+: A New Technical Adaptation
CF was introduced in clinical medicine in 1980. Up to now, exclusively two-vein procedures have been carried out with some… 
1988
1988
Concentration of bone marrow mononuclear cells for in vitro treatment and AB0-incompatible transplantation: a rapid and reproducible procedure using the haemonetics V50 cell separator.
Forty-nine allogeneic and 14 autologous bone marrow grafts were processed with the Haemonetics V50 cell separator (Haemonetics… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)